Back to GLENMEDE TRUST CO NA GLENMEDE TRUST CO NA

IARTIART
27 quarters

Position history for GLENMEDE TRUST CO NAGLENMEDE TRUST CO NA's holdings in INTEGRA LIFESCIENCES HLDGS C

GLENMEDE TRUST CO NA holds 984,686 shares of IART (INTEGRA LIFESCIENCES HLDGS C), worth $9.3M as of 2026-Q1. The position was increased (+27.4% shares). IART represents 0.0% of GLENMEDE TRUST CO NA's portfolio.

Current Value

$9.3M

Current Shares

984,686

Total Value Change

-$13.7M

Total Shares Change

+635,731

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
984,686
+27.4%
$9.3M0.0%$10.56
34
2025-Q4
Increased
772,912
+9.7%
$9.6M0.0%$12.68
30
2025-Q1
Decreased
704,325
-2.4%
$15.5M0.1%$21.69
0
2024-Q4
Decreased
721,811
-0.8%
$16.4M0.1%$22.47
0
2024-Q3
Increased
727,781
+125.9%
$13.2M0.1%$17.87
45
2024-Q2
Increased
322,157
+0.9%
$9.4M0.0%$29.14
28
2024-Q1
Increased
319,420
+7.7%
$11.3M0.1%$35.45
30
2023-Q4
Decreased
296,578
-3.1%
$12.9M0.1%$43.55
0
2023-Q3
Increased
306,032
+45.6%
$11.7M0.1%$38.19
38
2023-Q2
Increased
210,175
+0.2%
$11.9M0.1%$40.76
28
2023-Q1
New
209,767
-
$12M0.1%$56.52
39
2022-Q2
Exited
0
-100.0%
$00.0%$55.85
0
2022-Q1
Decreased
3,292
-4.4%
$211,0000.0%$65.71
0
2021-Q4
Decreased
3,443
-7.0%
$230,0000.0%$68.38
0
2021-Q3
Decreased
3,703
-7.8%
$253,0000.0%$70.45
0
2021-Q2
Increased
4,015
+3.2%
$273,0000.0%$68.52
24
2021-Q1
Decreased
3,889
-31.2%
$268,0000.0%$68.82
0
2020-Q4
Decreased
5,655
-12.7%
$367,0000.0%$65.05
0
2020-Q3
Increased
6,479
+5.3%
$305,0000.0%$46.42
25
2020-Q2
Increased
6,156
+36.3%
$289,0000.0%$46.48
30
2020-Q1
Unchanged
4,516
0.0%
$263,0000.0%$43.55
0
2019-Q4
Increased
4,516
+0.5%
$263,0000.0%$58.03
23
2019-Q3
Increased
4,495
+2.0%
$270,0000.0%$59.33
24
2019-Q2
Unchanged
4,406
0.0%
$246,0000.0%$55.85
0
2019-Q1
Decreased
4,406
-0.1%
$245,0000.0%$55.72
0
2018-Q4
Decreased
4,409
-98.7%
$198,0000.0%$44.33
0
2018-Q3
New
348,955
-
$23M0.1%$65.87
39

Other major holders of IART: Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used